Cargando…

Current progress in the development of prophylactic and therapeutic vaccines

Vaccines are essential public health tools and play an important role in reducing the burden of infectious diseases in the population. Emerging infectious diseases and outbreaks pose new challenges for vaccine development, requiring the rapid design and production of safe and effective vaccines agai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tingting, Qian, Ciying, Gu, Ying, Zhang, Jun, Li, Shaowei, Xia, Ningshao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science China Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734355/ https://www.ncbi.nlm.nih.gov/pubmed/36469218 http://dx.doi.org/10.1007/s11427-022-2230-4

Ejemplares similares

Current progress and challenges in the design and development of a successful COVID-19 vaccine
por: Li, Tingting, et al.
Publicado: (2021)

Recent Progress on the Versatility of Virus-Like Particles
por: Qian, Ciying, et al.
Publicado: (2020)

Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation
por: Li, Yike, et al.
Publicado: (2020)

Current progress in the development of a prophylactic vaccine for HIV-1
por: Gamble, Lena J, et al.
Publicado: (2010)

Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
por: Mo, Yicheng, et al.
Publicado: (2022)

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
por: Zhang, Zhiqing, et al.
Publicado: (2016)

Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction
por: Cai, Jing, et al.
Publicado: (2021)

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70
por: Qian, Ciying, et al.
Publicado: (2022)

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
por: Wang, Daning, et al.
Publicado: (2020)

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
por: Rozman, Marija, et al.
Publicado: (2022)

Prophylactic and therapeutic vaccines for obesity
por: Na, Ha-Na, et al.
Publicado: (2014)

Peptide Vaccines as Therapeutic and Prophylactic Agents for Female-Specific Cancers: The Current Landscape
por: Lekshmy, Manju, et al.
Publicado: (2023)

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection
por: Liu, Xinlin, et al.
Publicado: (2019)

Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
por: Huang, Yang, et al.
Publicado: (2020)

A review of the safety and efficacy of current COVID-19 vaccines
por: Huang, Zehong, et al.
Publicado: (2022)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines
por: Borovjagin, Anton V., et al.
Publicado: (2014)

Prophylactic and therapeutic DNA vaccines against Chagas disease
por: Arce-Fonseca, Minerva, et al.
Publicado: (2015)

Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination
por: Ko, Eun-Ju, et al.
Publicado: (2019)

COVID-19: Progress in diagnostics, therapy and vaccination
por: Liu, Xue, et al.
Publicado: (2020)

Current Progress in the Development of Zika Virus Vaccines
por: Zhou, Kehui, et al.
Publicado: (2021)

Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives
por: Major, Marian E.
Publicado: (2009)

The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines
por: Gordon, Benjamin, et al.
Publicado: (2020)

Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State
por: Akhatova, Ayazhan, et al.
Publicado: (2022)

Development of prophylactic vaccines against HIV-1
por: Schiffner, Torben, et al.
Publicado: (2013)

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design
por: Chen, Tingting, et al.
Publicado: (2023)

Escherichia coli-derived virus-like particles in vaccine development
por: Huang, Xiaofen, et al.
Publicado: (2017)

Current therapeutics and prophylactic approaches to treat pneumonia
por: Krishnamurthy, A., et al.
Publicado: (2016)

Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection
por: Ghasemi, Faezeh, et al.
Publicado: (2016)

Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody
por: Wang, Daning, et al.
Publicado: (2015)

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
por: Kumari, Monika, et al.
Publicado: (2022)

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells
por: Wang, Kaihang, et al.
Publicado: (2021)

Current status and progress of the development of prostate cancer vaccines
por: Wang, Jie, et al.
Publicado: (2023)

An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
por: Alagheband Bahrami, Armina, et al.
Publicado: (2022)

Cancer vaccines as promising immuno-therapeutics: platforms and current progress
por: Liu, Jian, et al.
Publicado: (2022)

Contralateral prophylactic mastectomy: current perspectives
por: Yao, Katharine, et al.
Publicado: (2016)

Advancements in prophylactic and therapeutic nanovaccines
por: Bhardwaj, Prateek, et al.
Publicado: (2020)

Genetic engineering of baculovirus-insect cell system to improve protein production
por: Hong, Minqing, et al.
Publicado: (2022)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

Zika Vaccine Development—Current Progress and Challenges for the Future
por: Maslow, Joel N.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oljecjpi2b47pblhm01474loet